(Q44599740)

English

Dose-Response Relationships of Inhaled Insulin Delivered via the Aerodose Insulin Inhaler and Subcutaneously Injected Insulin in Patients With Type 2 Diabetes

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

4 December 2017

Dose-Response Relationships of Inhaled Insulin Delivered via the Aerodose Insulin Inhaler and Subcutaneously Injected Insulin in Patients With Type 2 Diabetes (English)

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

internal medicine

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

author name string

Dennis Kim

1

1 reference

Europe PubMed Central

4 December 2017

Sunder Mudaliar

2

1 reference

Europe PubMed Central

4 December 2017

Sithipol Chinnapongse

3

1 reference

Europe PubMed Central

4 December 2017

Neelima Chu

4

1 reference

Europe PubMed Central

4 December 2017

Trent Davis

6

1 reference

Europe PubMed Central

4 December 2017

Robert Henry

10

1 reference

Europe PubMed Central

4 December 2017

Sarah M. Boies

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514589

15 March 2024

Ayesh D. Perera

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514589

15 March 2024

Robert S. Fishman

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514589

15 March 2024

David A. Shapiro

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514589

15 March 2024

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

4 December 2017

full work available at URL

1 reference

Europe PubMed Central

4 December 2017

26

1 reference

Europe PubMed Central

4 December 2017

10

1 reference

Europe PubMed Central

4 December 2017

2842-2847

1 reference

Europe PubMed Central

4 December 2017

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

1

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

2

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery

3

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes

6

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Time-action profile of inhaled insulin

8

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer

9

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus

10

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes.

11

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Pulmonary insulin administration using the AERx system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects.

13

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with noninsulin-dependent diabetes mellitus.

16

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Inhaled insulin

17

1 reference

10.2337/DIACARE.26.10.2842

https://api.crossref.org/works/10.2337/DIACARE.26.10.2842

15 March 2024

Identifiers

10.2337/DIACARE.26.10.2842

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44599740&oldid=2103804608"